Understanding the Teenage Brain

Understanding the Teenage Brain
Decision making and implications for informed consent

with Dr Sallie Baxendale

The Clinical Advisory Network On Sex & Gender welcomes you to the fourth in our series of interactive webinars.  These webinars will begin to cover the scope of our concerns and our work in the field of sex and gender in health care. 

In this presentation, Prof Baxendale will explore how the brain develops during adolescence and the impact this has on young people’s capacity to make decisions that have long term, irreversible consequences. She will examine how we can apply the neuroscience in a clinical setting to explore an individual's capacity to give informed consent for elective medical treatments. Although highly relevant in the care of young people struggling with their gender identity, the lessons from neuroscience are applicable to all clinicians working with adolescents and young people, whatever the medical setting.

Dr Sallie Baxendale is professor of clinical neuropsychology at the UCL, Queen Square, Institute of Neurology.

She has over three decades of clinical experience working with people with epilepsy in London and Oxford and is the current chair of the International League Against Epilepsy Diagnostic Methods Commission. She serves on the Board of Governors for the International Neuropsychological Society. She specialises in the neuropsychological assessment of cognitive and behavioural difficulties in epilepsy and non pharmacological interventions for the condition.

This event is free to register. There is a donation button at checkout. Our work is only possible thanks to the kind and generous donations of our members and supporters. All donations are gratefully received and go directly to our campaign costs. In appreciation, CAN-SG #FirstDoNoHarm 

Who are CAN-SG?

We're a group of 100 clinicians calling for greater understanding and respectful discourse on sex and gender in healthcare. We campaign for clearer dialogue, better data collection, rigorous science and improved treatment options for gender dysphoria. 

"First do no harm" means we take seriously the responsibility of all clinicians to examine potential harms associated with gender medicine and healthcare interventions especially when treating vulnerable populations. 

TWITTER  I  WEBSITE  I  FAQ  I  EMAIL  I  SIGN THE DECLARATION I  VIMEO